Atlas Trials

Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

Clinical trial NCT07003191 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07003191
Sponsor
Sun Yat-sen University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Type 2 Diabetes
Start date
2023-08-02
Primary completion
2025-12-31
Enrollment
2600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.